SCHEMBL4415818

SCHEMBL4415818

CC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3C=CC4=C[C@@](O)(Cl)CC[C@]4(C)[C@H]3CC[C@@]21C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.60
KMT2A Q03164 2/20 0.60
NR3C1 P04150 7/20 0.51
AR P10275 7/20 0.51
CYP3A4 P08684 7/20 0.51
PGR P06401 7/20 0.51
SMN1; SMN2 Q16637 4/20 0.51
ALDH1A1 P00352 4/20 0.51
MAPK1 P28482 3/20 0.51
NPSR1 Q6W5P4 3/20 0.51
CHRM2 P08172 3/20 0.51
CHRM1 P11229 3/20 0.51
HIF1A Q16665 2/20 0.51
USP2 O75604 2/20 0.51
TBXA2R P21731 2/20 0.51
CYP2C19 P33261 2/20 0.51
ADRA1A P35348 2/20 0.51
ADORA3 P0DMS8 1/20 0.51
THRB P10828 1/20 0.51
LMNA P02545 5/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4407552 1.00 MEN1 (0.60) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL4082890 0.82 MEN1 (0.63) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL4082888 0.82 MEN1 (0.63) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL149089 0.81 PGR (0.70) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL5925193 0.81 PGR (0.70) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL10390405 0.77 MEN1 (0.64) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL9169846 0.75 MEN1 (1.00) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL11798281 0.73 NR3C1 (0.67) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL10860460 0.73 NR3C1 (0.67) MEN1KMT2ANR3C1ARCYP3A4
SCHEMBL9168274 0.73 NR3C1 (0.67) MEN1KMT2ANR3C1ARCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8465763-B2 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases RICHTER GEDEON NYRT. (HU) 2013-06-18 US claimed
EP-2124924-B1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases GRUENENTHAL GMBH (DE) 2012-06-27 EP claimed
US-20090318395-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES GRUNENTHAL GMBH (DE) 2009-12-24 US claimed
US-20090312296-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES GRUNENTHAL GMBH (DE) 2009-12-17 US claimed
EP-2124924-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES Grünenthal GmbH (DE) 2009-12-02 EP claimed
EP-2124960-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2009-12-02 EP claimed
WO-2008077542-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2008-07-03 WO claimed
WO-2008077541-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES Grünenthal GmbH (DE) 2008-07-03 WO claimed
US-20140249117-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES RICHTER GEDEON NYRT. (HU) 2014-09-04 US disclosed
US-8465763-B2 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases RICHTER GEDEON NYRT. (HU) 2013-06-18 US disclosed
US-8465763-B2 3-hydroxychlormadinone acetate for the topical treatment of androgen-dependent skin diseases RICHTER GEDEON NYRT. (HU) 2013-06-18 US disclosed
EP-2124924-B1 Active ingredient combination of a retinoid and a hormone combination with contraceptive action as medicament for treatment of skin diseases GRUENENTHAL GMBH (DE) 2012-06-27 EP disclosed
US-20090318395-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES GRUNENTHAL GMBH (DE) 2009-12-24 US disclosed
US-20090318395-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES GRUNENTHAL GMBH (DE) 2009-12-24 US disclosed
EP-2124924-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES Grünenthal GmbH (DE) 2009-12-02 EP disclosed
EP-2124960-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2009-12-02 EP disclosed
EP-2124960-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2009-12-02 EP disclosed
WO-2008077541-A1 ACTIVE INGREDIENT COMBINATION OF A RETINOID AND A HORMONE COMBINATION WITH CONTRACEPTIVE ACTION AS MEDICAMENT FOR TREATMENT OF SKIN DISEASES Grünenthal GmbH (DE) 2008-07-03 WO disclosed
WO-2008077542-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2008-07-03 WO disclosed
WO-2008077542-A1 3-HYDROXYCHLORMADINONE ACETATE FOR THE TOPICAL TREATMENT OF ANDROGEN-DEPENDENT SKIN DISEASES Grünenthal GmbH (DE) 2008-07-03 WO disclosed